WynnVision, founded by Dr. Kenneth J. Wynne, is dedicated to advancing the field of chemical and physical characterization services. The company’s core mission is to provide comprehensive analytical solutions that help clients understand their surfaces better. WynnVision offers a variety of services, including ATR-IR, zeta potentials, water contact angles, and antimicrobial testing following ASTM guidelines. Their market focus is primarily on healthcare, where they aim to enhance the safety and efficacy of medical devices by preventing infections through innovative surface engineering.
Dr. Kenneth J. Wynne leads a team of scientist-engineers at WynnVision, who are at the forefront of developing rapid treatments for medical devices to combat infections. The company has made significant strides in engineering device surfaces to kill bacteria on contact and reduce biofilm formation. Notable achievements include the successful application of their technology to meet the urgent needs of the healthcare community. WynnVision's impact is evident in its contribution to safer medical practices and improved patient outcomes.
